Delivery Order SPE2DB20D3101-SPE2DB24FQUD5
- Not listed
- This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on September 29, 2023 with a ceiling value of $1,418.16. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a total potential value of $999,999,999.00 and runs through November 2026. This...
- This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract has a ceiling value of $118,415.12 and a completion date of April 17, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA) by Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The firm fixed price Delivery Order has a potential value of $7,047.30 and a completion date of February 13, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $52,881.80, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is April 15, 2025. The contract does not have a set-aside designation, indicating open...
- This federal contract award is a delivery order valued at $13,426.20 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, with a completion date of July 8, 2025. The contract has a firm fixed price pricing type and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML. The $1,217.72 fixed-price contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, to provide a comprehensive range of medical commodities, including pharmaceuticals and...
- This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a vaccine product, to the Defense Logistics Agency (DLA). The $35,454.00 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. This contract is not set aside and provides medical supplies to support military healthcare programs. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, which are pharmaceutical products. The contract, valued at $100,545.00, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical and medical supplies to the U.S. federal government. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is September 5, 2024. The contract does not have a set-aside...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,088.50, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price structure, and the ultimate completion date is July 16, 2024. The contract does not have a set-aside designation, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,179.50, is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of February 20, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp is the...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB24FQUD5Delivery Order
This federal contract award is for the delivery of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,023.35, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price, and the ultimate completion date is November 7, 2023. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/6/23 |